Cholecalciferol (Vitamin D3) Improves Myelination and Recovery after Nerve Injury
Open Access
- 31 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (5), e65034
- https://doi.org/10.1371/journal.pone.0065034
Abstract
Previously, we demonstrated i) that ergocalciferol (vitamin D2) increases axon diameter and potentiates nerve regeneration in a rat model of transected peripheral nerve and ii) that cholecalciferol (vitamin D3) improves breathing and hyper-reflexia in a rat model of paraplegia. However, before bringing this molecule to the clinic, it was of prime importance i) to assess which form – ergocalciferol versus cholecalciferol – and which dose were the most efficient and ii) to identify the molecular pathways activated by this pleiotropic molecule. The rat left peroneal nerve was cut out on a length of 10 mm and autografted in an inverted position. Animals were treated with either cholecalciferol or ergocalciferol, at the dose of 100 or 500 IU/kg/day, or excipient (Vehicle), and compared to unlesioned rats (Control). Functional recovery of hindlimb was measured weekly, during 12 weeks, using the peroneal functional index. Ventilatory, motor and sensitive responses of the regenerated axons were recorded and histological analysis was performed. In parallel, to identify the genes regulated by vitamin D in dorsal root ganglia and/or Schwann cells, we performed an in vitro transcriptome study. We observed that cholecalciferol is more efficient than ergocalciferol and, when delivered at a high dose (500 IU/kg/day), cholecalciferol induces a significant locomotor and electrophysiological recovery. We also demonstrated that cholecalciferol increases i) the number of preserved or newly formed axons in the proximal end, ii) the mean axon diameter in the distal end, and iii) neurite myelination in both distal and proximal ends. Finally, we found a modified expression of several genes involved in axogenesis and myelination, after 24 hours of vitamin supplementation. Our study is the first to demonstrate that vitamin D acts on myelination via the activation of several myelin-associated genes. It paves the way for future randomised controlled clinical trials for peripheral nerve or spinal cord repair.This publication has 69 references indexed in Scilit:
- A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosisNeurology, 2010
- Ca2+/Calmodulin-dependent Protein Kinase IV-mediated LIM Kinase Activation Is Critical for Calcium Signal-induced Neurite OutgrowthOnline Journal of Public Health Informatics, 2009
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesNature Protocols, 2008
- 1,25‐Dihydroxyvitamin D3 administration to 6‐hydroxydopamine‐lesioned rats increases glial cell line‐derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatumJournal of Neuroscience Research, 2008
- NFAT signaling in neural development and axon growthInternational Journal of Developmental Neuroscience, 2008
- Unc-51-like kinase 1/2-mediated endocytic processes regulate filopodia extension and branching of sensory axonsProceedings of the National Academy of Sciences of the United States of America, 2007
- Distribution of the Vitamin D receptor and 1α-hydroxylase in human brainJournal of Chemical Neuroanatomy, 2005
- LIMK1 Regulates Golgi Dynamics, Traffic of Golgi-derived Vesicles, and Process Extension in Primary Cultured NeuronsMolecular Biology of the Cell, 2004
- Insulin‐like growth factor 1 is essential for normal dendritic growthJournal of Neuroscience Research, 2003
- Changes in afferent activities from tibialis anterior muscle after nerve repair by self-anastomosisMuscle & Nerve, 2001